Mega Lifesciences PCL (BKK:MEGA)
Thailand flag Thailand · Delayed Price · Currency is THB
35.00
0.00 (0.00%)
Sep 3, 2026, 4:36 PM ICT

Mega Lifesciences PCL Cash Flow Statement

Millions THB. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
2,1901,9122,0121,9932,2421,947
Depreciation & Amortization
271.45278.13277.74279.98265.18268.86
Other Amortization
5.195.195.695.896.835.57
Loss (Gain) From Sale of Assets
-2.22-5.32-2.65-2.87-2.08-3.51
Asset Writedown & Restructuring Costs
-0.75-0.8-0.59-0.548.5928.02
Loss (Gain) on Equity Investments
7.580.33-0.15-0.07-0.181.51
Provision & Write-off of Bad Debts
13.067.783.6812.175.833.09
Other Operating Activities
115.35235.21251.64238.7270.439.8
Change in Accounts Receivable
-605.33-442.14231.3-322.23-631.4718.02
Change in Inventory
-533.01-82.38447.19569.37-576.69-273.63
Change in Accounts Payable
187.2467.31-278.66-885.27364.68375.68
Change in Other Net Operating Assets
1,110795.14-546.2838.65243.99316.59
Operating Cash Flow
2,7592,7702,4011,9261,9972,727
Operating Cash Flow Growth
66.64%15.37%24.65%-3.51%-26.78%67.35%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-547.63-663.89-247.53-274.65-304.6-151.4
Sale of Property, Plant & Equipment
2.294.2817.724.532.866.47
Cash Acquisitions
-28.19----9.25-
Sale (Purchase) of Intangibles
-2.95-3.12-9.76-18.93-8.14-8.38
Investment in Securities
-6.36-6.38178.14-20.11-1.75-122.57
Other Investing Activities
88.7884.4362.8759.1440.0711.19
Investing Cash Flow
-494.07-584.691.45-250.01-280.83-264.68

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-205.23215.37-65.2-
Total Debt Issued
66.14205.23215.37-65.2-
Short-Term Debt Repaid
----148.66--309.49
Long-Term Debt Repaid
--57.64-60.16-88.6-58.1-53.52
Total Debt Repaid
-59.16-57.64-60.16-237.26-58.1-363.01
Net Debt Issued (Repaid)
6.98147.59155.21-237.267.1-363.01
Common Dividends Paid
-1,395-1,395-1,395-1,439-1,406-922.94
Other Financing Activities
-60.43-49.51-38.04-31.75-34.76-27.93
Financing Cash Flow
-1,449-1,297-1,277-1,708-1,433-1,314

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
37.75-78.9-19.42-64.92-26.7642.98
Net Cash Flow
293.44809.951,106-96.74255.771,191

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2,2122,1072,1541,6521,6922,575
Free Cash Flow Growth
94.48%-2.20%30.39%-2.38%-34.30%84.62%
Free Cash Flow Margin
15.22%14.84%14.00%10.51%10.76%18.17%
Free Cash Flow Per Share
2.542.422.471.901.942.95
Levered Free Cash Flow
1,7222,0812,2891,4131,2091,989
Unlevered Free Cash Flow
1,7602,1162,3141,4331,2272,006

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
60.4349.5138.0431.7529.8527.93
Cash Income Tax Paid
536.94373.99362.3423.09389.5362.76
Change in Working Capital
159.28337.93-146.45-599.47-599.49436.66